These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 5012543)

  • 1. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders.
    Lowe GD
    Br Med J (Clin Res Ed); 1983 Apr; 286(6373):1262-4. PubMed ID: 6404416
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the effect of pyrithioxine on cerebral changes in aging].
    Hofmann G; Salvendy JT
    Wien Z Nervenheilkd Grenzgeb; 1968; 26(3):279-84. PubMed ID: 4235305
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of Pyritinol (Encephabol) in psychiatry].
    Wardaszko-Lyskowska H; Zardecka-Mieścicka M
    Psychiatr Pol; 1970; 4(2):161-7. PubMed ID: 5427760
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of nicotinyl alcohol in delayed-action form in some obstetrical gynecological vascular diseases].
    De Marini M
    Minerva Ginecol; 1969 Jan; 21(2):63-6. PubMed ID: 5776754
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasodilator drugs and peripheral vascular disease.
    Drug Ther Bull; 1972 Nov; 10(23):91-2. PubMed ID: 4144248
    [No Abstract]   [Full Text] [Related]  

  • 7. [A delayed-action therapeutic agent in chronic cerebral circulatory insufficiencies].
    Boudouresques J; Papy JJ; Daniel F
    Therapeutique; 1970 Oct; 46(8):789-92. PubMed ID: 5458910
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent experiences with pyrithioxine in the treatment of various nervous system diseases in children].
    Lesný I; Rössler M; Tokalaki L
    Cesk Pediatr; 1974 Oct; 29(10):562-4. PubMed ID: 4442189
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of peripheral arterial insufficiency with inositoli nicotinas (Hexanicit).
    Hentzer E
    Scand J Clin Lab Invest Suppl; 1967; 99():226-32. PubMed ID: 4862834
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the circulatory physiology and biochemistry of cerebral degeneration processes and influencing the behavior of patients with drug therapy].
    Cornu F
    Wien Klin Wochenschr; 1969 Jun; 81(23):426-31. PubMed ID: 5790194
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical responses to Cinnarizin in various psychiatric syndromes.
    Szobor A; Klein M
    Ther Hung; 1973; 21(1):31-4. PubMed ID: 4792889
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychopharmacological treatment of disorders of senescence.
    Fann WE; Wheless JC; Richman BW
    N C Med J; 1974 Nov; 35(11):672-7. PubMed ID: 4530160
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

  • 14. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
    De Gregorio G; Restivo S
    Clin Ter; 1982 Dec; 103(5):501-7. PubMed ID: 7160142
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of cerebral vascular insufficiency syndromes in old age. Controlled research by double blind technic].
    Mars G; Nebuloni G
    G Gerontol; 1970 Mar; 18(3):153-76. PubMed ID: 4919664
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the therapy of cerebral and peripheral circulatory disorders in general practice].
    Risse S
    Med Welt; 1967 Jul; 28():1659-62. PubMed ID: 5612140
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the therapy of central and peripheral blood circulation disorders].
    Weihrauch H
    Hippokrates; 1967 Sep; 38(18):739-42. PubMed ID: 5610064
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of pyrithioxine combined with a vasodilator in patients with cerebral arteriosclerosis].
    Schlesinger P
    Rev Bras Med; 1972 Jan; 29(1):38-41. PubMed ID: 4552863
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases].
    Dotti GC
    Minerva Med; 1973 May; 64(34):1821-30. PubMed ID: 4719379
    [No Abstract]   [Full Text] [Related]  

  • 20. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders].
    Hamming JJ; van der Drift JH
    Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.